Patent · US Expired

Skin-adhering pharmaceutical preparation, in particular transdermal therapeutic system for the release of 17-.beta.-estradiol to the human organism

US6267982A · kind A · utility

1Cited by
1References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 17, 1999
Grant dateJul 31, 2001
Priority date
Expiry dateMar 17, 2019

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P19/10
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A pharmaceutical preparation adhering to the skin, in particular a TTS, for the release of the active substance 17-.beta.-estradiol, the concentration of the estradiol contained therein in dissolved form being between its saturation concentration in equilibrium with a gas phase of less than 10% relative air humidity and its saturation concentration in equilibrium with a gas phase of more than 90% relative air humidity, in all matrix layers and, if present, also in an adhesive layer, characterized in that the estradiol quantity contained in the preparation amounts to at least three times the saturation solubility measured at 95% relative air humidity, and that the air enclosed in the package is adjusted to a relative air humidity between 5% and below 0.5%.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.